These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12386568)

  • 1. Expression of basic fibroblast growth factor and its receptor-1 in cardiac myxoma.
    Fujisawa H; Koide N; Kono T; Takayama K; Tsukioka K; Wada Y; Zhang T; Kitahara H; Nakano H; Suzuki JI; Isobe M; Amano J
    J Cardiovasc Surg (Torino); 2002 Oct; 43(5):589-94. PubMed ID: 12386568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor and angiogenesis in cardiac myxoma: a study of fifteen patients.
    Kono T; Koide N; Hama Y; Kitahara H; Nakano H; Suzuki J; Isobe M; Amano J
    J Thorac Cardiovasc Surg; 2000 Jan; 119(1):101-7. PubMed ID: 10612767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma.
    Zhang T; Koide N; Wada Y; Tsukioka K; Takayama K; Kono T; Kitahara H; Amano J
    Circ J; 2003 Jan; 67(1):54-60. PubMed ID: 12520153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive dynamic fluorescence imaging of human melanomas reveals that targeted inhibition of bFGF or FGFR-1 in melanoma cells blocks tumor growth by apoptosis.
    Valesky M; Spang AJ; Fisher GW; Farkas DL; Becker D
    Mol Med; 2002 Feb; 8(2):103-12. PubMed ID: 12080186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of basic fibroblast growth factor and its receptor in renal cell carcinoma].
    Zhong H; Deng F; Kong X
    Zhonghua Wai Ke Za Zhi; 1996 Nov; 34(11):651-4. PubMed ID: 9590749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibroblast growth factor receptors, FGFR-1 and FGFR-2, mediate two independent signalling pathways in human retinal pigment epithelial cells.
    Rosenthal R; Malek G; Salomon N; Peill-Meininghaus M; Coeppicus L; Wohlleben H; Wimmers S; Bowes Rickman C; Strauss O
    Biochem Biophys Res Commun; 2005 Nov; 337(1):241-7. PubMed ID: 16188231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tumor vascularisation in benign and malignant cardiovascular neoplasms: a comparison of cardiac myxoma and sarcomas of the pulmonary artery.
    Gaumann A; Strubel G; Bode-Lesniewska B; Schmidtmann I; Kriegsmann J; Kirkpatrick CJ
    Oncol Rep; 2008 Aug; 20(2):309-18. PubMed ID: 18636191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma.
    Ueki T; Koji T; Tamiya S; Nakane PK; Tsuneyoshi M
    J Pathol; 1995 Dec; 177(4):353-61. PubMed ID: 8568589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression.
    Guddo F; Fontanini G; Reina C; Vignola AM; Angeletti A; Bonsignore G
    Hum Pathol; 1999 Jul; 30(7):788-94. PubMed ID: 10414497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding.
    Roghani M; Mansukhani A; Dell'Era P; Bellosta P; Basilico C; Rifkin DB; Moscatelli D
    J Biol Chem; 1994 Feb; 269(6):3976-84. PubMed ID: 8307953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers.
    Takanami I; Tanaka F; Hashizume T; Kikuchi K; Yamamoto Y; Yamamoto T; Kodaira S
    Eur J Cancer; 1996 Aug; 32A(9):1504-9. PubMed ID: 8911109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.
    Straume O; Akslen LA
    Am J Pathol; 2002 Mar; 160(3):1009-19. PubMed ID: 11891198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
    Wu X; Blanck A; Olovsson M; Möller B; Lindblom B
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):497-504. PubMed ID: 11380284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular localization of basic fibroblast growth factor and fibroblast growth factor receptor 1 in pituitary adenomas.
    Fukui S; Otani N; Nawashiro H; Yano A; Nomura N; Miyazawa T; Ohnuki A; Tsuzuki N; Katoh H; Ishihara S; Shima K
    Brain Tumor Pathol; 2002; 19(1):23-9. PubMed ID: 12455885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.
    Bian XW; Du LL; Shi JQ; Cheng YS; Liu FX
    Anal Quant Cytol Histol; 2000 Jun; 22(3):267-74. PubMed ID: 10872046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of a transfected FGFR-1 receptor in Madin-Darby epithelial cells results in a reversible loss of epithelial properties.
    Migdal M; Soker S; Yarden Y; Neufeld G
    J Cell Physiol; 1995 Feb; 162(2):266-76. PubMed ID: 7529769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma.
    Giehl KA; Nägele U; Volkenandt M; Berking C
    J Cutan Pathol; 2007 Jan; 34(1):7-14. PubMed ID: 17214848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR).
    Hueber A; Wiedemann P; Esser P; Heimann K
    Int Ophthalmol; 1996-1997; 20(6):345-50. PubMed ID: 9237137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.
    Panek RL; Lu GH; Dahring TK; Batley BL; Connolly C; Hamby JM; Brown KJ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):569-77. PubMed ID: 9655904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression and nuclear accumulation of basic fibroblast growth factor in primary cultured astrocytes following ischemic-like insults.
    Liu X; Zhu XZ
    Brain Res Mol Brain Res; 1999 Aug; 71(2):171-7. PubMed ID: 10521571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.